Hutch News

Hutch News

Stories tagged 'Irwin D Bernstein'

Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia

Hutch-based repository leads to lifesaving treatments for young cancer patient

Aug. 29, 2017 | By Sabrina Richards / Fred Hutch News Service

A unique, Hutch-based repository of tissue samples ‘ready to teach’ lifesaving lessons about childhood leukemia.

View story >


Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >


‘I want this to be something everyone can get’

New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein

Dec. 3, 2015 | By Susan Keown / Fred Hutch News Service

A new Fred Hutch spinoff, Nohla Therapeutics, will commercialize cord blood stem cell therapies based on work by Dr. Colleen Delaney and Dr. Irwin Bernstein. In preliminary studies, the company’s first product helps stem cells engraft more quickly after transplant and protects patients from deadly infections during this vulnerable period.

View story >


Meeting someone who saved your life

Bone marrow transplant recipient and reunion volunteer shares story of meeting her donor

July 23, 2015 | By Megan Herndon / Fred Hutch News Service

Earlier this summer, Dena Fantle met Ethan Lax, the 23-year-old who saved her life from aplastic anemia with a donation of his bone marrow.

View story >


The ripples of a life

20 years after Dr. Harold Weintraub’s death, his life — and his research — are still making a difference

May 1, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Twenty years after his death at the age of 49, friends, family and colleagues remember Dr. Hal Weintraub — and gather today at the Weintraub Graduate Student Award symposium established in his honor.

View story >


Two Center researchers receive Damon Runyon awards

Immunotherapy research funded for Drs. Brian Till and Colleen Delaney

July 6, 2010 | By Dean Forbes

Two Fred Hutchinson Cancer Research Center researchers who study immunotherapy—how the body’s immune system can be trained to fight cancer—have received prestigious awards from the Damon Runyon Cancer Research Foundation.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.